Efficacy in Patient Subgroups in the INCREASE Trial, a Phase III Trial to Evaluate Inhaled Treprostinil in Patients with Pulmonary Hypertension Due to Parenchymal Lung Disease

被引：0
|
作者：
Tapson, Victor [1 ]
Nathan, Steven [2 ]
Girgis, Reda [3 ]
Runo, James [4 ]
Bag, Remzi [5 ]
Talwar, Arunabh [6 ]
Smith, Peter [7 ]
Edwards, Lisa [7 ]
Park, Christine [7 ]
Waxman, Aaron [8 ]
机构：
[1] Cedars Sinai, Los Angeles, CA USA
[2] Inova Fairfax, Falls Church, VA USA
[3] Michigan State Univ, Lansing, MI USA
[4] Univ Wisconsin, Madison, WI USA
[5] Univ Chicago, Chicago, IL 60637 USA
[6] Hofstra Northwell Sch Med, Hempstead, NY USA
[7] United Therapeut Corp, Durham, NC USA
[8] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0497
引用
收藏
页码：1030 / 1032
页数：3
相关论文
共 50 条
  • [1] Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial
    Nathan, Steven D.
    Tapson, Victor F.
    Elwing, Jean
    Rischard, Franz
    Mehta, Jinesh
    Shapiro, Shelley
    Shen, Eric
    Deng, Chunqin
    Smith, Peter
    Waxman, Aaron
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (02) : 198 - +
  • [2] Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension Due to Parenchymal Lung Disease in the INCREASE Trial
    Nathan, S. D.
    Tapson, V. F.
    Elwing, J. M.
    Rischard, F. P.
    Mehta, J. P.
    Shapiro, S.
    Shen, E.
    Edwards, L.
    Smith, P. M.
    Waxman, A. B.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [3] Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
    Waxman, Aaron
    Restrepo-Jaramillo, Ricardo
    Thenappan, Thenappan
    Ravichandran, Ashwin
    Engel, Peter
    Bajwa, Abubakr
    Allen, Roblee
    Feldman, Jeremy
    Argula, Rahul
    Smith, Peter
    Rollins, Kristan
    Deng, Chunqin
    Peterson, Leigh
    Bell, Heidi
    Tapson, Victor
    Nathan, Steven D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (04): : 325 - 334
  • [4] A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension Due to Parenchymal Lung Disease (Study RIN-PH-201)
    Waxman, A. B.
    Tapson, V. F.
    Smith, P. M.
    Deng, C.
    Nathan, S. D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [5] Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease
    Sakao, Seiichiro
    Kondoh, Yasuhiro
    Kinoshita, Hideyuki
    Nishiyama, Osamu
    Ogo, Takeshi
    Tanabe, Nobuhiro
    Minatsuki, Shun
    Nakayama, Kazuhiko
    Taniguchi, Yu
    Takahashi, Kenta
    Takatsu, Masahiro
    Ogura, Takashi
    [J]. RESPIRATORY INVESTIGATION, 2024, 62 (06) : 980 - 986
  • [6] Plain language summary of the INCREASE study: inhaled treprostinil (Tyvaso) for the treatment of pulmonary hypertension due to interstitial lung disease
    West, Natalie
    Smoot, Karen
    Patzlaff, Natalie
    Miceli, Melissa
    Waxman, Aaron
    [J]. FUTURE CARDIOLOGY, 2023, 19 (05) : 229 - 239
  • [7] COMPARISON OF EFFECTS OF INHALED TREPROSTINIL ON LUNG FUNCTION IN PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND PULMONARY ARTERIAL HYPERTENSION
    Nathan, Steven
    Tapson, Victor
    Ramani, Gautam
    Medarov, Boris
    Levine, Deborah
    Burger, Charles
    El-Kersh, Karim
    Shen, Eric
    Rao, Youlan
    Smith, Peter
    Waxman, Aaron
    [J]. CHEST, 2021, 160 (04) : 2244A - 2246A
  • [8] Safety and tolerability of inhaled treprostinil with phosphodiesterase-5 inhibitors in patients with pulmonary hypertension due to interstitial lung disease
    Zisman, David
    Dubrock, Hilary
    King, Christopher
    Weaver, Sheila
    Nathan, Steven
    Rahaghi, Franck
    Kim, Hyoshin
    Rao, Youlan
    Shen, Eric
    Waxman, Aaron
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [9] Inhaled treprostinil in patients with pulmonary hypertension due to interstitial lung disease: event-free survival in INCREASE study open-label extension
    Nathan, S.
    Argula, R.
    Rajagopal, S.
    Johri, S.
    De La Zerda, D.
    Mcglothlin, D.
    Smith, P.
    Deng, C.
    Miceli, M.
    Tapson, V
    Waxman, A.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [10] Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study
    Waxman, Aaron
    Restrepo-Jaramillo, Ricardo
    Thenappan, Thenappan
    Engel, Peter
    Bajwa, Abubakr
    Ravichandran, Ashwin
    Feldman, Jeremy
    Case, Amy Hajari
    Argula, Rahul G.
    Tapson, Victor
    Smith, Peter
    Deng, Chunqin
    Shen, Eric
    Nathan, Steven D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (06)
12345